News

Archives
15 Apr 2013

The National Cancer Institute (U.S) has recently labelled Aspirin in Colorectal Cancer as one of the most provocative questions in cancer

The National Cancer Institute (U.S) has recently labelled Aspirin in Colorectal Cancer as one of the most provocative questions in cancer (http://provocativequestions.nci.nih.gov/). According to the NCI’s website, delineating the molecular pathways behind aspirin’s anti-cancer effect will be game changing and lead to new breakthroughs in the understanding of cancer. We are therefore extremely pleased that all of us are part of this important endeavour.